Hypoxic tumor cells are forced to reprogram metabolic pathways, from oxygen-dependent mitochondrial oxidative phosphorylation to oxygen-independent glycolysis, favoring the hypoxia-driven increased bioavailability of different RAGE ligands such as AGEs and HMGB1 within the TME [195]. Here, HMGB1 is linked to neoplasm.